Clinical Trials
80 trialsOnTRAC
St. Jude Children's Research Hospital
COVAR
Institut Curie
Care Plans for Cancer Predisposition
Children's Hospital of Philadelphia
Bundled Cancer Screening and Genetic Services Navigation
Georgetown University
EXGEFATU
University Hospital Tuebingen
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
St. Jude Children's Research Hospital
MRIMOP
University Hospital, Montpellier
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
Dana-Farber Cancer Institute
MyeloGen
Dana-Farber Cancer Institute
SJFAMILY
St. Jude Children's Research Hospital
Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition
St. Jude Children's Research Hospital
PRECEDE
Arbor Research Collaborative for Health
PRE-PDAC
Catholic University of the Sacred Heart
Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon
Duke University
EX²TRICAN
Centre Georges Francois Leclerc
Microbiome and Association With Implant Infections
University of California, San Francisco
IMPACT
Institute of Oncology Ljubljana
Healthy Volunteers Study
Abramson Cancer Center at Penn Medicine
The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).
Institute of Cancer Research, United Kingdom
Blood Markers of Early Pancreas Cancer
University of Nebraska
Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study
Dana-Farber Cancer Institute
Key LARGO
Duke University
MPGx-INDALL
University of Geneva, Switzerland
Genetic Susceptibility to Bladder Cancer
M.D. Anderson Cancer Center
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Abramson Cancer Center at Penn Medicine
Genetic Investigation of Cancer Predisposition
The University of Texas Health Science Center at San Antonio
PMPRC
Institute of Cancer Research, United Kingdom
PTX3AML
Centre Hospitalier Universitaire Vaudois
BRIDGEScohort2
Institut Curie
PTBB
Abramson Cancer Center at Penn Medicine
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
Institute of Cancer Research, United Kingdom
Genetic Information Assistant in Telegenetics
University of Virginia
CANHPARI
Assistance Publique - Hôpitaux de Paris
A Model for Genetic Susceptibility: Melanoma
Memorial Sloan Kettering Cancer Center
NICHE
Columbia University
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
University of Pennsylvania
INHERIT
Dana-Farber Cancer Institute
Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model
Abramson Cancer Center at Penn Medicine
PPPC
Royal Marsden NHS Foundation Trust
Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
King Hussein Cancer Center
MyCancerGene
Abramson Cancer Center at Penn Medicine
RNSM
University Health Network, Toronto
ExpoMel
University Hospital Tuebingen
Early Detection of GEnetic Risk (EDGE)
University of Washington
PROGRESS
Massachusetts General Hospital
Investigating the Role of Genetics in Disease Predisposition
The Wellcome Sanger Institute
WANDA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OnBRA
IRCCS San Raffaele
ALARM3
Assistance Publique - Hôpitaux de Paris
Family History Study on Cancer Risk
Kaiser Permanente